Skip to main content
Equibles

FMR LLC

Position in KLRA — Kailera Therapeutics, Inc.

CIK 315066 BOSTON, MA
Back to KLRA Full portfolio

Position in KLRA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$87,478,155
New position
Shares Held
3,970,865
first reported quarter
Ownership
3.06%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 99 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority Sole 100% Shared 0% None 0%

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FMR LLC holds $61,908,415,112 across 370 Biotechnology names. KLRA ranks #104 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 5,231,452 $4,853,584,218
2 ALNY
Alnylam Pharmaceuticals, Inc.
 15,023,962 $4,522,663,276
3 MRNA
Moderna, Inc.
 51,859,891 $3,631,748,165
4 ROIV
Roivant Sciences Ltd.
 81,020,390 $2,867,311,601
5 RVMD
Revolution Medicines, Inc.
 12,200,422 $2,284,895,029
6 IONS
Ionis Pharmaceuticals Inc
 24,631,956 $1,953,067,789
7 INSM
INSMED Inc
 16,143,583 $1,721,228,815
8 KRYS
Krystal Biotech, Inc.
 4,418,197 $1,642,111,277

All Filings in KLRA

Export CSV
1 filing row on record
Report Date Value (USD) Shares
2026-06-30 $87,478,155 3,970,865